Fairvalue-Calculator Fairvalue-Calculator
EN DE

Psyence Group (PSYGF) Fair Value & Analysis

Healthcare · US · Market cap $2.0M

Price$0.1270
Fair Value$0.1800
Upside+41.7%
Quality80/100
Evidence: Low Range $0.1200 – $0.2300

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Psyence Group (PSYGF) currently trades at $0.1270, while our model-based Fair Value estimate is $0.1800 — implying the stock looks roughly 41.7% undervalued today. We read business quality at 80/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Psyence Group Inc., a life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma. It operates in two segments, Clinical Trial Activities and Non-Clinical Trial Activities. The company develops botanical psilocybin-based psychedelic medicine, which works with natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. It also focuses on the research and development, cultivation, and production of psilocybin mushrooms and functional over-the-counter mushroom products. The company offers its functional mushroom products under the GOODMIND brand. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada.

Open the full interactive analysis →

Similar stocks

Eli Lilly and Company (LLY) -64% Johnson & Johnson, (JNJ) -29% AbbVie Inc (ABBV) -42% Roche Holding (ROGN) -4% Merck & Co (MRCK34) -35% AstraZeneca PLC (A1ZN34) -31%

Frequently asked questions

Is Psyence Group (PSYGF) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.1800 versus a price of $0.1270 — about +42% (undervalued). Model-based estimate, not financial advice.
What is the fair value of PSYGF?
Our 21-model fair value for Psyence Group is $0.1800 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.1270.
What is the quality score of PSYGF?
Psyence Group has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.